The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Open accessAbstract
Apoptosis is crucial for the normal development of the nervous system, whereas neurons in the adult CNS are relatively resistant to this form of cell death. However, under pathological conditions, upregulation of death receptor family ligands, such as tumour necrosis factor (TNF), can sensitize cells in the CNS to apoptosis and a form of regulated necrotic cell death known as necroptosis that is mediated by receptor-interacting protein kinase 1 (RIPK1), RIPK3 and mixed lineage kinase domain-like protein (MLKL). Necroptosis promotes further cell death and neuroinflammation in the pathogenesis of several neurodegenerative diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Parkinson disease and Alzheimer disease. In this Review, we outline the evidence implicating necroptosis in these neurological diseases and suggest that targeting RIPK1 might help to inhibit multiple cell death pathways and ameliorate neuroinflammation. Necroptosis is a form of cell death mediated by receptor-interacting protein kinase 1 (RIPK1), and is observed in several CNS disorders. Here, Yuan, Amin and Ofengeim give an overview of necroptosis in the CNS and explain its relationship with inflammation in CNS disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increased activation of TNF/TNFR1 signalling following chronic activation of microglia can give rise to TNF-mediated necroptotic neuronal cell death, 160 which represents a possible therapeutic target in Parkinson's disease.161”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [161]
Experimental — accuracy not yet measuredIn the citing paper
“Yet, several genes that have been implicated in neuroinflammation38 (such as RIPK1) were seen specifically in microglial states associated with COVID-19.”
From Dysregulation of brain and choroid plexus cell types in severe COVID-19 (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068
Self-citationInduction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
Sun, L., Wang, H., Wang, Z., He, S., Chen, S., Liao, D., Wang, L., Yan, J., Liu, W., Lei, X., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.031 · Cited by 2,698
Ji, Y. (1993) · Cell · doi:10.1016/0092-8674(93)90485-9 · Cited by 2,497
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435
Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130
Identification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059
Self-citation
Cited by
Sorted by citations
Emerging connectivity of programmed cell death pathways and its physiological implications
Bedoui, S., Herold, M. J., & Strasser, A. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0270-8 · Cited by 1,027
The mechanism of HMGB1 secretion and release
Chen, R., Kang, R., & Tang, D. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00736-w · Cited by 928
Inflammasomes in neuroinflammatory and neurodegenerative diseases
Voet, S., Srinivasan, S., Lamkanfi, M., & van Loo, G. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201810248 · Cited by 761
Malireddi, R. K. S., Kesavardhana, S., & Kanneganti, T. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00406 · Cited by 787
Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications
Tuo, Q., Zhang, S., & Lei, P. (2021) · Medicinal Research Reviews · doi:10.1002/med.21817 · Cited by 758
Dysregulation of brain and choroid plexus cell types in severe COVID-19
Yang, A. C., Kern, F., Losada, P. M., Agam, M. R., Maat, C. A., Schmartz, G. P., Fehlmann, T., Stein, J. A., Schaum, N., Lee, D. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03710-0 · Cited by 620
Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome
Liu, Y., Fang, Y., Chen, X., Wang, Z., Liang, X., Zhang, T., Liu, M., Zhou, N., Lv, J., Tang, K., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aax7969 · Cited by 566
Shan, S., Zhang, Y., Zhao, H., Zeng, T., & Zhao, X. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.134261 · Cited by 556
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Mifflin, L., Ofengeim, D., & Yuan, J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0071-y · Cited by 508
Self-citationOxidative stress and regulated cell death in Parkinson’s disease
Dionísio, P. A., Amaral, J. D., & Rodrigues, C. M. P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101263 · Cited by 443
Necroptosis: a crucial pathogenic mediator of human disease
Choi, M. E., Price, D. R., Ryter, S. W., & Choi, A. M. K. (2019) · JCI Insight · doi:10.1172/jci.insight.128834 · Cited by 428
Targeting RIPK1 for the treatment of human diseases
Degterev, A., Ofengeim, D., & Yuan, J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1901179116 · Cited by 415
Self-citationMitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosis
Weindel, C. G., Martinez, E. L., Zhao, X. L., Mabry, C. J., Bell, S. L., Vail, K. J., Coleman, A. K., VanPortfliet, J. J., Zhao, B., Wagner, A. R., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.038 · Cited by 404
Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities
Schmidt, M. F., Gan, Z. Y., Komander, D., & Dewson, G. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00706-7 · Cited by 379
Microglia: Agents of the CNS Pro-Inflammatory Response
Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A. (2020) · Cells · doi:10.3390/cells9071717 · Cited by 365
Diversity and complexity of cell death: a historical review
Park, W., Wei, S., Kim, B., Kim, B., Bae, S., Chae, Y. C., Ryu, D., & Ha, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01078-x · Cited by 381
Cell death pathways: intricate connections and disease implications
Kist, M., & Vucic, D. (2021) · The EMBO Journal · doi:10.15252/embj.2020106700 · Cited by 337
Webster, J. D., & Vucic, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00365 · Cited by 324
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., & Lan, J. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1201982 · Cited by 293
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Neuronal Death Mechanisms and Therapeutic Strategy in Ischemic Stroke
Mao, R., Zong, N., Hu, Y., Chen, Y., & Xu, Y. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00859-0 · Cited by 296
A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1
Tao, P., Sun, J., Wu, Z., Wang, S., Wang, J., Li, W., Pan, H., Bai, R., Zhang, J., Wang, Y., et al. (2019) · Nature · doi:10.1038/s41586-019-1830-y · Cited by 278
Self-citationOxidative stress and the role of redox signalling in chronic kidney disease
Kishi, S., Nagasu, H., Kidokoro, K., & Kashihara, N. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00775-0 · Cited by 297
TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus
Jayaraman, A., Htike, T. T., James, R., Picón, C., & Reynolds, R. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01264-w · Cited by 244
The Role of Mitochondria in Inflammation: From Cancer to Neurodegenerative Disorders
Missiroli, S., Genovese, I., Perrone, M., Vezzani, B., Vitto, V. A. M., & Giorgi, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030740 · Cited by 235
MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease
Balusu, S., Horré, K., Thrupp, N., Craessaerts, K., Snellinx, A., Serneels, L., T’Syen, D., Chrysidou, I., Arranz, A. M., Sierksma, A. S. R., et al. (2023) · Science · doi:10.1126/science.abp9556 · Cited by 246
Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer’s Disease
Lewcock, J. W., Schlepckow, K., Di Paolo, G., Tahirovic, S., Monroe, K. M., & Haass, C. (2020) · Neuron · doi:10.1016/j.neuron.2020.09.029 · Cited by 221
The double-edged functions of necroptosis
Ye, K., Chen, Z., & Xu, Y. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05691-6 · Cited by 239
Apoptotic cell death regulation in neurons
Hollville, É., Romero, S. E., & Deshmukh, M. (2019) · FEBS Journal · doi:10.1111/febs.14970 · Cited by 216
Song, S., Ding, Y., Dai, G., Zhang, Y., Xu, M., Shen, J., Chen, T., Chen, Y., & Meng, G. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0490-7 · Cited by 212
Cui, Y., Zhang, Z., Zhou, X., Zhao, Z., Zhao, R., Xu, X., Kong, X., Ren, J., Yao, X., Wen, Q., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02231-x · Cited by 208
Necroptosis contributes to chronic inflammation and fibrosis in aging liver
Mohammed, S., Thadathil, N., Selvarani, R., Nicklas, E. H., Wang, D., Miller, B. F., Richardson, A., & Deepa, S. S. (2021) · Aging Cell · doi:10.1111/acel.13512 · Cited by 192
Advances in mechanism and regulation of PANoptosis: Prospects in disease treatment
Zhu, P., Ke, Z.-R., Chen, J.-X., Li, S., Ma, T., & Fan, X.-L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1120034 · Cited by 200
Flipping the dogma – phosphatidylserine in non-apoptotic cell death
Shlomovitz, I., Speir, M., & Gerlic, M. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0437-0 · Cited by 189
Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases
Wang, L., Zhu, Y., Zhang, L., Guo, L., Wang, X., Pan, Z., Jiang, X. L., Wu, F., & He, G. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06370-2 · Cited by 198
Progress in understanding the role of lncRNA in programmed cell death
Jiang, N., Zhang, X., Gu, X., Li, X., & Shang, L. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00407-1 · Cited by 179
Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance
Shahar, N., & Larisch, S. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100712 · Cited by 175
Mechanisms underlying progression in multiple sclerosis
Absinta, M., Lassmann, H., & Trapp, B. D. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000818 · Cited by 175
Fatty acid metabolism in the progression and resolution of CNS disorders
Bogie, J. F. J., Haidar, M., Kooij, G., & Hendriks, J. J. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.01.004 · Cited by 167
Naito, M. G., Xu, D., Amin, P. P., Lee, J., Wang, H., Li, W., Kelliher, M. A., Pasparakis, M., & Yuan, J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916427117 · Cited by 159
Self-citationZhāng, Q., Xiong, K., Yan, W., Yang, Y., Hu, X., Ning, W.-Y., Liao, L.-S., Lu, S., & Zhao, W. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.331539 · Cited by 160
Ferroptosis and Liver Fibrosis
Pan, Q., Luo, Y., Xia, Q., & He, K. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.62903 · Cited by 155
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases
Patel, S. D., Webster, J. D., Varfolomeev, E. E., Kwon, Y. C., Cheng, J. H., Zhang, J., Dugger, D. L., Wickliffe, K. E., Maltzman, A., Sujatha-Bhaskar, S., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0347-0 · Cited by 152
Human TBK1 deficiency leads to autoinflammation driven by TNF-induced cell death
Taft, J., Markson, M., Legarda, D., Patel, R., Chan, M., Malle, L., Richardson, A., Gruber, C., Martín-Fernández, M., Mancini, G. M. S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.026 · Cited by 151
Ashraf, U., Ding, Z., Deng, S., Ye, J., Cao, S., & Chen, Z. (2021) · Virulence · doi:10.1080/21505594.2021.1899674 · Cited by 150
Insight into Crosstalk between Ferroptosis and Necroptosis: Novel Therapeutics in Ischemic Stroke
Zhou, Y., Liao, J., Mei, Z., Liu, X., & Ge, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9991001 · Cited by 151
Xu, C., Wu, J. S., Wu, Y., Ren, Z., Yao, Y., Chen, G., Fang, E. F., Noh, J. H., Liu, Y., Wei, L., et al. (2021) · Theranostics · doi:10.7150/thno.62376 · Cited by 151
Gao, Y., Zhang, H., Zhou, N., Xu, P., Wang, J., Gao, Y., Jin, X., Liang, X., Lv, J., Zhang, Y., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0583-0 · Cited by 144
Liu, M., Li, H., Yang, R., Ji, D., & Xia, X. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02626-4 · Cited by 149
PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons
Yan, W., Zhao, W., Hu, X., Ban, X.-X., Ning, W.-Y., Wan, H., Zhāng, Q., & Xiong, K. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.346545 · Cited by 144
Park, H.-H., Kim, H.-R., Park, S.-Y., Hwang, S., Hong, S. M., Park, S., Kang, H. C., Morgan, M. J., Cha, J., Lee, D., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01399-3 · Cited by 141
Zhang, X., Tang, B., Luo, J., Yang, Y., Weng, Q., Fang, S., Zhao, Z., Tu, J., Chen, M., & Ji, J. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02130-8 · Cited by 148
Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches
Ding, P.-F., Zhang, H., Wang, J., Gao, Y., Mao, J.-N., Hang, C., & Li, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1092431 · Cited by 143
Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration
Neel, D. V., Basu, H., Gunner, G., Bergstresser, M., Giadone, R. M., Chung, H., Miao, R., Chou, V., Brody, E. M., Jiang, X., et al. (2023) · Neuron · doi:10.1016/j.neuron.2023.02.019 · Cited by 147
SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration
Ko, K. W., Milbrandt, J., & DiAntonio, A. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.201912047 · Cited by 137
RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis
Zelic, M., Pontarelli, F., Woodworth, L. A., Zhu, C., Mahan, A. L., Ren, Y., LaMorte, M. J., Gruber, R. C., Keane, A. M., Loring, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109112 · Cited by 138
Self-citationPark, J., Ha, H.-J., Chung, E. S., Baek, S. H., Cho, Y., Kim, H. K., Han, J., Sul, J. H., Lee, J., Kim, E., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd3207 · Cited by 139
Necroptosis: A Novel Pathway in Neuroinflammation
Yu, Z., Jiang, N., Su, W., & Zhuo, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.701564 · Cited by 134
The potential role of necroptosis in inflammaging and aging
Royce, G. H., Brown‐Borg, H. M., & Deepa, S. S. (2019) · GeroScience · doi:10.1007/s11357-019-00131-w · Cited by 137
Neuroinflammation: The central enabler of postoperative cognitive dysfunction
Liu, Y., Yang, W., Xue, J., Chen, J., Liu, S., Zhang, S., Zhang, X., Gu, X., Dong, Y., & Qiu, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115582 · Cited by 139
The necroptosis machinery mediates axonal degeneration in a model of Parkinson disease
Oñate, M., Catenaccio, A., Salvadores, N., Saquel, C., Martinez, A. N., Moreno‐González, I., Gamez, N., Rudolffi-Soto, P., Soto, C. A., Hetz, C. A., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0408-4 · Cited by 133
Causes of and Molecular Targets for the Treatment of Intervertebral Disc Degeneration: A Review
Ohnishi, T., Iwasaki, N., & Sudo, H. (2022) · Cells · doi:10.3390/cells11030394 · Cited by 130
Hu, Y., Liu, Y., Zong, L., Zhang, W., Liu, R., Xing, Q., Liu, Z., Yan, Q., Li, W., Lei, H., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06382-y · Cited by 140
Hou, J., Ju, J., Zhang, Z., Zhao, C., Li, Z., Zheng, J., Tian, S., Zhang, H., Hu, L., Yu, X., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1735-6 · Cited by 125
Metabolic orchestration of cell death by AMPK-mediated phosphorylation of RIPK1
Zhang, T., Xu, D., Trefts, E., Lv, M., Inuzuka, H., Song, G., Liu, M., Lu, J., Liu, J., Chu, C., et al. (2023) · Science · doi:10.1126/science.abn1725 · Cited by 122
Self-citationDong, Y., Yu, H., Li, X., Bian, K., Zheng, Y., Dai, M., Feng, X., Sun, Y., He, Y. T., Yu, B., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02567-y · Cited by 127
miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson’s disease
Hu, Y.-B., Zhang, Y., Wang, H., Ren, R., Cui, H., Huang, W., Cheng, Q., Chen, H., & Wang, G. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1809-5 · Cited by 119
Cell Death and NeurodegenerationPreprint
Andreone, B. J., Larhammar, M., & Lewcock, J. W. (2019) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a036434 · Cited by 124
ROS-Mediated Necroptosis Is Involved in Iron Overload-Induced Osteoblastic Cell Death
Tian, Q., Qin, B., Gu, Y., Zhou, L., Chen, S., Zhang, S., Zhang, S., Han, Q., Liu, Y., & Wu, X. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1295382 · Cited by 116
Single-nucleus transcriptomic landscape of primate hippocampal aging
Zhang, H., Li, J., Ren, J., Sun, S., Ma, S., Zhang, W., Yu, Y., Cai, Y., Yan, K., Li, W., et al. (2021) · Protein & Cell · doi:10.1007/s13238-021-00852-9 · Cited by 122
Wang, X., & Jia, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114473 · Cited by 120
Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives
Zhuang, C., & Chen, F. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01317 · Cited by 116
Vissers, M. F. J. M., Heuberger, J. A. A. C., Groeneveld, G. J., Nijhuis, J. O., Deyn, P. P. D., Hadi, S., Harris, J. M., Tsai, R. M., Cruz-Herranz, A., Huang, F., et al. (2022) · Clinical and Translational Science · doi:10.1111/cts.13317 · Cited by 116
Different types of cell death in diabetic endothelial dysfunction
Shen, J., San, W., Zheng, Y., Zhang, S., Cao, D., Chen, Y., & Meng, G. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115802 · Cited by 117
Neuroimmune Mechanisms Underlying Neuropathic Pain: The Potential Role of TNF-α-Necroptosis Pathway
Duan, Y.-W., Chen, S., Li, Q., & Zang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137191 · Cited by 117
The pseudokinase MLKL regulates hepatic insulin sensitivity independently of inflammation
Xu, H., Du, X., Liu, G., Huang, S., Du, W., Zou, S., Tang, D., Fan, C., Xie, Y., Wei, Y., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.02.003 · Cited by 112
Research trends, hot spots and prospects for necroptosis in the field of neuroscience
Xiong, K., Yan, W., Lu, S., Yang, Y., Ning, W.-Y., Cai, Y., Hu, X.-M., & Zhāng, Q. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303032 · Cited by 107
Mohammed, S., Nicklas, E. H., Thadathil, N., Selvarani, R., Royce, G. H., Kinter, M. T., Richardson, A. G., & Deepa, S. S. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.449 · Cited by 110
Qin, Q., Yu, N., Gu, Y., Ke, W., Zhang, Q., Liu, X., Wang, K., & Chen, M. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04911-9 · Cited by 111
Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter
Picón, C., Jayaraman, A., James, R., Beck, C., Gallego, P., Witte, M. E., van Horssen, J., Mazarakis, N. D., & Reynolds, R. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02274-7 · Cited by 108
Current translational potential and underlying molecular mechanisms of necroptosis
Molnár, T., Mázló, A., Tslaf, V., Szöllősi, A. G., Emri, G., & Koncz, G. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2094-z · Cited by 110
Deep Generative Models in De Novo Drug Molecule Generation
Pang, C., Qiao, J., Zeng, X., Zou, Q., & Wei, L. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01496 · Cited by 113
Tao, L., Yi, Y., Chen, Y., Zhang, H., Jie, J., Zhang, W., Xu, Q., Li, Y., Ørning, P., Lien, E., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00668-w · Cited by 105
Zhou, S., Zhang, W., Cai, G., Ding, Y., Wei, C., Li, S., Yu, Y., Qin, J., Liu, D., Zhang, H., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00393-6 · Cited by 105
Li, X., Zhang, M., Huang, X., Liang, W. P., Li, G., Lu, X., Li, Y., Pan, H., Shi, L., Zhu, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19935-y · Cited by 99
Self-citationCordaro, M., Cuzzocrea, S., & Crupi, R. (2020) · Antioxidants · doi:10.3390/antiox9030216 · Cited by 98
Zhang, H., Ni, W., Yu, G., Geng, Y., Lou, J., Qi, J., Chen, Y., Li, F., Ye, H., Ma, H., et al. (2023) · Theranostics · doi:10.7150/thno.78370 · Cited by 101
Harris, P. A., Marinis, J. M., Lich, J. D., Berger, S. B., Chirala, A., Cox, J. A., Eidam, P. M., Finger, J. N., Gough, P. J., Jeong, J. U., et al. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00108 · Cited by 94
Humanin: A mitochondrial-derived peptide in the treatment of apoptosis-related diseases
Hazafa, A., Batool, A., Ahmad, S., Amjad, M., Chaudhry, S. N., Asad, J., Ghuman, H. F., Khan, H. M., Naeem, M., & Ghani, U. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118679 · Cited by 96
SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation
Xu, G., Li, Y., Zhang, S., Peng, H., Wang, Y., Li, D., Jin, T., He, Z., Tong, Y., Qi, C., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00578-7 · Cited by 95
Self-citationSignaling cascades in the failing heart and emerging therapeutic strategies
He, X., Du, T., Long, T., Liao, X., Dong, Y., & Huang, Z. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00972-6 · Cited by 108
RIPK protein kinase family: Atypical lives of typical kinases
Cuny, G. D., & Degterev, A. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.06.014 · Cited by 95
Gong, Z., Guo, J., Liu, B., Guo, Y., Cheng, C., Jiang, Y., Liang, N., Hu, M., Song, T., Yang, L., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1287857 · Cited by 97
RIPK3 signaling and its role in regulated cell death and diseases
Zhou, Y., Xiang, Y., Liu, S., Li, C., Dong, J., Kong, X., Ji, X., Cheng, X., & Zhang, L. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01957-w · Cited by 97
Astrocyte-Mediated Neuroinflammation in Neurological Conditions
Zhao, Y., Huang, Y., Cao, Y., & Yang, J. H. (2024) · Biomolecules · doi:10.3390/biom14101204 · Cited by 106
Fibrillar α-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-κB
Chou, T.-W., Chang, N. P., Krishnagiri, M., Patel, A. P., Lindman, M., Angel, J. P., Kung, P.-L., Atkins, C., & Daniels, B. P. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04049-0 · Cited by 93
Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death
Clucas, J., & Meier, P. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00623-w · Cited by 96
Papazian, I., Tsoukala, E., Boutou, A., Καραμίτα, Μ., Kambas, K., Iliopoulou, L., Fischer, R., Kontermann, R. E., Denis, M. C., Kollias, G. A., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02200-4 · Cited by 86
Ultrasmall iron oxide nanoparticles induced ferroptosis via Beclin1/ATG5-dependent autophagy pathway
Wen, J., Chen, H., Ren, Z., Zhang, P., Chen, J., & Jiang, S. (2021) · Nano Convergence · doi:10.1186/s40580-021-00260-z · Cited by 86
Wang, N., & Liu, D. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s342613 · Cited by 84
Metadata
- Authors
- Yuan, J., Amin, P., & Ofengeim, D.
- Affiliations
- Harvard University (US)
- Sanofi (United States) (US)
- Corresponding author
- Yuan, Junying
- Venue
- Nature Reviews Neuroscience
- Published
- 2018-11-22
- Volume
- 20
- Issue
- 1
- Pages
- 19-33
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- PMC
- PMC6342007
- OpenAlex
- W2901410206
- Semantic Scholar
- a6626d511f6ce29e1ffd0f9740b5c693cadb4fb3
- Cited by
- 967
- References
- 179
- Citations by year
- 2026: 110 · 2025: 156 · 2024: 149 · 2023: 152 · 2022: 164 · 2021: 134 · 2020: 65 · 2019: 35
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Denali Therapeutics
- National Institutes of Health (4r01ns082257-04)
- National Institute on Aging (RF1AG055521, R01AG047231, R21AG059073)
- National Institute of Neurological Disorders and Stroke (R01-NS082257)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- necroptosis, RIPK1, neuroinflammation, RIPK3, MLKL, apoptosis, TNF-α, death receptor ligands, neurodegenerative diseases, multiple sclerosis, amyotrophic lateral sclerosis, Parkinson's disease, Alzheimer's disease, central nervous system disorders
- MeSH terms
- Necroptosis, Animals, Brain, Humans, Inflammation, Neurons, Phosphorylation, Neurodegenerative Diseases, Receptor-Interacting Protein Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review